Home Top Movers Is This Why Nkarta (NKTX) Stock Rises Premarket?

Is This Why Nkarta (NKTX) Stock Rises Premarket?

In premarket trading, shares of biopharmaceutical company developing engineered NK cell therapies to treat cancer Nkarta Inc. (NASDAQ: NKTX) rose 14.62% to $29.71 at last check. Last session, Nkarta closed at $25.92, decreasing by -5.30% or $1.45. In the course of the day, price of NKTX stock fluctuated in the range from $24.50 to $27.23.  On news of strategic oncology research collaboration, NKTX stock has been rising.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What is the collaboration for?

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Biotech company Nkarta is developing natural killer (NK) cell therapy for the treatment of cancer with allogeneic tissue. Through the combination of its cell expansion and cryopreservation platform with proprietary cell engineering technologies, NKTX is developing a pipeline of cell therapy candidates that can help patients by improving the cell’s targeting ability and persistence in the body.

Read More

Nkarta and CRISPR Therapeutics have announced yesterday a strategic partnership for the development, research, and commercialization of CRISPR/Cas9 gene-edited cell therapies specifically for cancer.

  • As a result of the agreement, NKTX will work together with CRISPR to co-produce and co-market two CAR-NK cell candidates, one targeting the CD70 tumor antigen and second a to-be-determined target.
  • In addition, NKTX will combine its skills in cell therapy engineering and manufacturing with that of CRISPR to further develop a novel NK+T product candidate harnessing synergistic effects of the immune system’s innate and adaptive components.
  • Last but not least, NKTX obtains a license to CRISPR gene-editing technology that can edit 5 gene targets in a multitude of their own NK cell therapy products.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

How the collaboration will work?

Nkarta (NKTX) and CRISPR will share equally all R&D and profits related to the collaboration products worldwide. NKTX will hold worldwide rights to every non-collaboration product candidate that incorporates a CRISPR Therapeutics gene-editing target, and will pay CRISPR Therapeutics on net sales for product milestones and royalties.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Related News

Sorrento Therapeutics Inc. (SRNE) stock gained during after-hours. Here’s what you should know

Sorrento Therapeutics Inc. (NASDAQ: SRNE) stock surged by 1.6% at the last close while the SRNE stock price rises by 5.07% in the after-hours...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Here’s why Soligenix, Inc. (SNGX) stock is Popping High today

Soligenix, Inc. (SNGX) stock gained Pediatric Investigation Plan (PIP) waiver for HyBryte™ (SGX301 or hypericin) by European Medicines Agency (EMA) after which the SNGX...

Clover Health Investments Corp. (CLOV) stock rises during pre-market. Let’s find out why?

Clover Health Investments Corp. (NASDAQ: CLOV) stock declined by 23.61% at last close while the CLOV stock price gains by 5.73% in the pre-market...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam